Mining potentially actionable kinase gene fusions in cancer cell lines with the KuNG FU database

Alessio Somaschini1, Sebastiano Di Bella1, Carlo Cusi1

  • 1NMS Oncology, Nerviano Medical Sciences, NMS Group, 20014, Nerviano, Milan, Italy.

Scientific Data
|December 1, 2020
PubMed

Insights

Kinase gene fusions (KGFs) are key cancer targets. The KuNG FU database offers a comprehensive, curated resource for these fusions identified in cell lines, aiding drug development.

Area of Science:

  • Oncology
  • Genetics
  • Bioinformatics

Background:

  • Kinase gene fusions (KGFs) are validated targets in cancer therapy due to their druggability.
  • Existing data on KGFs is often fragmented, hindering targeted drug development and diagnostics.
  • There is a need for a centralized, curated database of KGFs.

Purpose of the Study:

  • To introduce KuNG FU, a manually curated database of kinase gene fusions.
  • To provide detailed molecular and experimental annotations for KGFs.
  • To support targeted drug development and diagnostic approaches for cancer.

Main Methods:

  • Manual curation of KGF data from multiple sources.
  • Focus on in-frame KGF events with intact kinase domains from human cancer cell lines.
  • Inclusion of experimentally validated KGFs.

Main Results:

  • KuNG FU is a freely accessible, homogeneous, and curated database.
  • It contains detailed annotations on KGFs identified in cell line models.
  • Represents the largest such database to date.

Conclusions:

  • KuNG FU addresses the need for consolidated KGF information.
  • Facilitates research and development of targeted cancer therapies.
  • Enables better understanding of KGFs as potential driver oncogenes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K